TH
BIO icon

Timber Hill’s Bio-Rad Laboratories Class A BIO Stock Holding History

Timber Hill’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-963
Closed -$214K – 633
2017
Q3 		$214K Buy
+963
New +$217K 0.02% 545
2017
Q2 		– Sell
-1,442
Closed -$287K – 1029
2017
Q1 		$287K Buy
+1,442
New +$278K ﹤0.01% 1780

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HCM
Hitchwood Capital Management New York $184M AUM 3.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Timber Hill's BIO Position: Q4 2017 in Review

Timber Hill sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2017, closing a stake of 963 shares — an estimated $214K sold.

Timber Hill first reported a position in BIO in Q1 2017 and held it in 2 quarters. The position peaked at $287K in Q1 2017. 302 funds tracked by Wall St. Rank hold BIO as of Q4 2017.

  • Timber Hill reported no remaining Bio-Rad Laboratories Class A position as of Q4 2017 after selling out during the quarter.
  • Timber Hill sold 963 Bio-Rad Laboratories Class A shares in Q4 2017, an estimated $214K.
  • Timber Hill first reported a position in Bio-Rad Laboratories Class A in Q1 2017 and held it in 2 quarters.
  • Timber Hill's Bio-Rad Laboratories Class A position peaked at $287K in Q1 2017.
  • 302 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2017.

Based on Timber Hill's 13F filing for Q4 2017, filed 9 Feb 2018.